What happened with the FDA and compounded GLP-1s, and who is still operating legally?

Short answer

• The FDA moved strongly against pharmacies compounding unapproved copies of GLP‑1 drugs (semaglutide, tirzepatide and similar) — especially when made from bulk active pharmaceutical ingredients (APIs) of unknown or unapproved source. The agency issued warning letters, asked some pharmacies to stop, and has pursued enforcement where patient safety or the law was violated.
• That doesn’t mean all compounding pharmacies were shut down. Legally operating options today are (a) FDA‑approved brand GLP‑1 products dispensed with a valid prescription, (b) state‑licensed pharmacies compounding only in ways allowed under federal and state law (individualized prescriptions, using approved sources), and (c) FDA‑registered 503B outsourcing facilities that meet FDA requirements.

What the FDA’s actions were, in plain terms

• FDA’s position: pharmacists and outsourcing facilities may not compound essentially a copy of an FDA‑approved drug or routinely compound from bulk drug substances unless that substance is on an FDA‑approved/allowed list and the compounding fits statutory limits. The agency has said compounding from unknown/unverified bulk API sources raises safety risks (incorrect dose, contamination, sterility problems, bad labeling) and is often unlawful.
• Enforcement steps: warning letters, public advisories, seizures and injunctions in cases where pharmacies compounded prohibited products or used suspect bulk APIs. State boards of pharmacy have also taken actions in many states.

Who can still operate legally (and how to get GLP‑1 therapy safely)

1. FDA‑approved manufacturers and branded products

   • Get prescriptions filled as the labeled drugs from the original manufacturers/brand names: e.g., Novo Nordisk’s semaglutide products (Ozempic, Wegovy) and Eli Lilly’s tirzepatide products (Mounjaro, Zepbound). These are manufactured under FDA approval and distributed through normal supply chains and specialty pharmacies.
   • Why: these have known quality, labeled dosing, established safety data and manufacturer support programs.

2. Retail and specialty pharmacies dispensing FDA‑approved product

   • Large retail chains and reputable specialty pharmacies (examples: CVS, Walgreens, Walmart, and specialty/pharmacy benefit manager pharmacies such as Accredo, Optum Specialty, Diplomat) will dispense brand product with a prescription.
   • Why: they source approved product from authorized distributors and are subject to state/federal oversight.

3. 503B outsourcing facilities that are registered with and inspected by FDA

   • Outsourcing facilities that follow current good manufacturing practice (cGMP) and FDA rules may legally make certain compounded products in larger lots. They must be registered and typically list their compliance publicly.
   • Why: 503B registration + FDA inspection is the path for larger‑scale compounding when allowed.

4. State‑licensed (503A) compounding pharmacies — with limits

   • 503A pharmacies may compound for an individual patient’s prescription but may not lawfully compound an unapproved copy of an already‑approved drug or routinely compound from bulk APIs that are not allowed. Many 503A pharmacies stopped making GLP‑1 compound products or restricted compounding to compliant scenarios after FDA guidance and enforcement.

Red flags — buy from a different source if:

• A seller offers “cheap” or over‑the‑counter GLP‑1s without a valid prescription.
• A pharmacy won’t disclose the API source or provide certificates of analysis (COAs).
• The product comes from an overseas/unverified supplier or from an online vendor that won’t show licensure or inspection status.

How you can verify a specific provider

• Ask the pharmacy for: state pharmacy license number, whether they’re a registered 503B outsourcing facility (if applicable), COA for the batch, and proof of sourcing for the API.
• Check the FDA Warning Letters database and your state board of pharmacy website for actions against a named pharmacy.
• When in doubt, get the prescription filled through your clinic’s usual channel or a major retail or specialty pharmacy.

If you want, I can:

• Check whether a specific compounding pharmacy or outsourcing facility has an active FDA action or warning (give me the name and state), or
• Point you to manufacturer patient‑support programs and specialty pharmacies for getting FDA‑approved GLP‑1s.